Exit-site care in peritoneal dialysis

Contributions to Nephrology

Volumn 154, Issue , 2007, Pages 117-124

  Wadhwa, Nand K ^a   Reddy, Gampala H ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMUCHINA; ANTIINFECTIVE AGENT; CHLORHEXIDINE; HYPOCHLOROUS ACID; POVIDONE IODINE; SOAP; SODIUM CHLORIDE; TOPICAL ANTIINFECTIVE AGENT;

BANDAGE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN CARE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; CATHETERS, INDWELLING; CHLORHEXIDINE; EQUIPMENT CONTAMINATION; HUMANS; HYPOCHLOROUS ACID; INFECTION CONTROL; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; POVIDONE-IODINE; SKIN CARE; SOAPS; SODIUM CHLORIDE;

EID: 33751551878     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000096955     Document Type: Review

References (32)

1. Flanigan M, Gokal R: Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int 2005;25:132-139.
2. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al: Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25:107-131.
3. Golper TA, Brier ME, Bunke M: Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 Peritonitis and Catheter Survival Studies. Am J Kidney Dis 1996;38:428-436.
4. Lye WC, Lee EJ, Tan CC: Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand J Urol Nephrol 1992;26:177-180.
5. Wikdahl AM, Engman U, Stegmayr BG, Sorenssen JG: One dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol Dial Transplant 1997;12:157-160.
6. Gadallah MF, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S: Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am J Kidney Dis 2000;36:1014-1019.
7. Mupirocin Study Group: Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol 1996;7:2403-2408.
8. Prowant BF, Warady BA, Nolph KD: Peritoneal dialysis catheter exit-site care: results of an international study. Perit Dial Int 1993;13:149-154.
9. Prowant BF, Twardowski ZJ: Recommendations for exit care. Perit Dial Int 1996;16(suppl 3):S94-S99.
10. Twardowski ZJ, Prowant BF: Classification of normal and diseased exit sites. Perit Dial Int 1996;16(suppl 3):S32-S50.
11. Twardowski ZJ, Prowant BF: Exit-site healing post catheter implantation. Perit Dial Int 1996;16(suppl 3): S51-S68.
12. Turner K, Edgar D, Hair M, Uttley L, Sternland R, Hunt L, et al: Does catheter immobilization reduce exit-site infection in CAPD? in Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG (eds): Advances in Peritoneal Dialysis. Toronto, Peritoneal Dialysis Bulletin, 1992, vol 8, pp 265-268.
13. Lineaweaver W, Howard R, Soney D: Topical antimicrobial toxicity. Arch Surg 1985;120:267-270.
14. Twardowski ZJ, Prowant BF, Pickett B, Nichols WF, Nolph KD, Khanna R: Four-year experience with swan neck presternal peritoneal dialysis catheter. Am J Kidney Dis 1996;27:99-105.
15. Starzomski RC: Three techniques for peritoneal catheters exit site dressings. ANNA J 1984;11:9-16.
16. Khanna R, Oreopoulos DG: Clinical management of patients on CAPD. Perit Dial Bull 1983;3:54-57.
17. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM: Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infec Dis 2003;37:1629-1638.
18. Lobbedez T, Gardam M, Dedier H, Burdzy D, Chu M, Izatt S, et al: Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant 2004;19:3140-3143.
19. Piraino B, Bernardini J, Florio T, Fried L: Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients. Adv Perit Dial 2003;19:198-201.
20. Bernardini J, Bender B, Florio T, Sloand J, PalmMontalbano L, Fried L, et al: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection inperitoneal dialysis patients. J Am Soc Nephrol 2005;16:539-545.
21. Wadhwa NK, Suh H, Cabralda T, Stratos J, Cascio C, Irwin C, Folz B: A randomized trial of amuchina 10% versus povidone-iodine 10% solution for exit-site care/infection in peritoneal dialysis patients. Perit Dial Int 1995;15:S1-S64.
22. Wadhwa NK, Suh H, Cabralda T: Amuchina 5% versus povidone-iodine 10% solution for exit-site care/infection in peritoneal dialysis patients. Perit Dial Int 1997;17:S1-S46.
23. Cabralda T, Wadhwa NK, Suh H: Use of amuchina 50% solution versus povidone-iodine 10% solution for transfer set change in peritoneal dialysis patients. Advances Perit Dial 1998;14:142-144.
24. Luzar MA, Brown C, Balf D, Hill L, Issad B, Monnier B, et al: Exit-site care and exit-site infection in continous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit Dial Bull 1990;10:25-29.
25. Warady BA, Jackson MA, Millspaugh J, Miller RM, Ford DM, Hellerstein M, et al: Prevention and treatment of catheter related infections in children. Perit Dial Bull 1987;7:34-36.
26. Hazelton Laboratories American, Inc., Guinea Pig Maximization Test, September 10, 1986.
27. Clementi R: Universita degli Studi di Milano, 4-Week Subchronic Dermal Study in Rabbits. Experiment No. 25, 1986.
28. Bianchi P, Repetto A, Bulletti So, et al: In vitro study on the antifungine activity of two chlorine-based antiseptics. Ann Ig, Prev Community Med 1989;1:827-840.
29. Bernardini J, Piraino B, et al: An analysis of ten-year trends in infections in adults on CAPD. Clin Nephrol 1991;36:29-34.
30. Fuchs J, Gallagher E, Jackson-Bey D, Krawtz D, Schreiber MJ: A prospective randomized study of peritoneal catheter exit-site care. Dial Transplant 1990;19:81-84.
31. Mishkin GJ, Ogilvie J, Mishkin M: 10% electrolytic chloroxidizing agent (ExSept Plus) to reduce infection rates in dialysis pts. Am J Kidney Dis 2002;39:A24.
32. Astle CM, Jensen L: A trial of ExSept for hemodialysis central venous catheters. Nephro Nurs J 2005;32:517-525.